These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31816324)

  • 1. Peptides derived from the C-terminal domain of HIV-1 Viral Protein R in lipid bilayers: Structure, membrane positioning and gene delivery.
    Marquette A; Leborgne C; Schartner V; Salnikov E; Bechinger B; Kichler A
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183149. PubMed ID: 31816324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.
    Solbak SM; Wray V; Horvli O; Raae AJ; Flydal MI; Henklein P; Henklein P; Nimtz M; Schubert U; Fossen T
    BMC Struct Biol; 2011 Dec; 11():49. PubMed ID: 22185200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells.
    Coeytaux E; Coulaud D; Le Cam E; Danos O; Kichler A
    J Biol Chem; 2003 May; 278(20):18110-6. PubMed ID: 12639957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating the activity of the channel-forming segment of Vpr protein from HIV-1.
    Chen CP; Kremer C; Henklein P; Schubert U; Fink RH; Fischer WB
    Eur Biophys J; 2010 Jun; 39(7):1089-95. PubMed ID: 19629466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism.
    Bruns K; Fossen T; Wray V; Henklein P; Tessmer U; Schubert U
    J Biol Chem; 2003 Oct; 278(44):43188-201. PubMed ID: 12881523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Insights into the Conformational Dynamics of HIV-1 Vpr in a Lipid Bilayer for Ion Channel Modeling.
    Majumder S; Deganutti G; Pipitò L; Chaudhuri D; Datta J; Giri K
    J Chem Inf Model; 2024 Apr; 64(8):3360-3374. PubMed ID: 38597744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of HIV-2 Vpx and Vpr proteins is regulated by the presence or absence of zinc-binding sites and poly-proline motifs with distinct roles.
    Shimagaki K; Koga R; Fujino H; Ahagon A; Tateishi H; Otsuka M; Yamaguchi Y; Fujita M
    J Gen Virol; 2020 Sep; 101(9):997-1007. PubMed ID: 32553018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
    Singh SP; Tomkowicz B; Lai D; Cartas M; Mahalingam S; Kalyanaraman VS; Murali R; Srinivasan A
    J Virol; 2000 Nov; 74(22):10650-7. PubMed ID: 11044109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.
    Barnitz RA; Chaigne-Delalande B; Bolton DL; Lenardo MJ
    PLoS One; 2011; 6(9):e24924. PubMed ID: 21949789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of human immunodeficiency virus type 1 Vpr(13-33) peptide in micelles.
    Engler A; Stangler T; Willbold D
    Eur J Biochem; 2001 Jan; 268(2):389-95. PubMed ID: 11168374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural studies of synthetic peptide fragments derived from the HIV-1 Vpr protein.
    Luo Z; Butcher DJ; Murali R; Srinivasan A; Huang Z
    Biochem Biophys Res Commun; 1998 Mar; 244(3):732-6. PubMed ID: 9535734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and purification of soluble HIV-2 viral protein R (Vpr) using a sandwich-fusion protein strategy.
    Hänel K; Möckel L; Brummel M; Peiris K; Hartmann R; Dingley AJ; Willbold D; Loidl-Stahlhofen A
    Protein Expr Purif; 2014 Mar; 95():156-61. PubMed ID: 24380802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-proline motif in HIV-2 Vpx is critical for its efficient translation.
    Miyake A; Fujita M; Fujino H; Koga R; Kawamura S; Otsuka M; Ode H; Iwatani Y; Sakai Y; Doi N; Nomaguchi M; Adachi A; Miyazaki Y
    J Gen Virol; 2014 Jan; 95(Pt 1):179-189. PubMed ID: 24114794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions.
    Schüler W; Wecker K; de Rocquigny H; Baudat Y; Sire J; Roques BP
    J Mol Biol; 1999 Feb; 285(5):2105-17. PubMed ID: 9925788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides.
    Davoodi S; Bolhassani A; Sadat SM; Irani S
    Biotechnol Lett; 2019 Nov; 41(11):1283-1298. PubMed ID: 31531750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
    Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
    PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
    Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
    PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation.
    Mahalingam S; Khan SA; Murali R; Jabbar MA; Monken CE; Collman RG; Srinivasan A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3794-8. PubMed ID: 7731985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
    Cassiday PA; DePaula-Silva AB; Chumley J; Ward J; Barker E; Planelles V
    Virology; 2015 Feb; 476():19-25. PubMed ID: 25499532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.